41mon MSN
Corona Remedies IPO day 2: Nearly 3x subscription so far; check GMP trends & should you apply?
Corona Remedies’ Rs 655-crore IPO entered Day 2 after achieving 62% subscription on Day 1, driven largely by retail demand.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback